Novartis India

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
787.90
10.5 (1.35%)
BSENSE

Feb 04

BSE+NSE Vol: 12.55 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 333626,
    "name": "Novartis India",
    "stock_name": "Novartis India",
    "full_name": "Novartis India Ltd",
    "name_url": "stocks-analysis/novartis-india",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "787.90",
    "chg": 10.5,
    "chgp": "1.35%",
    "dir": 1,
    "prev_price": "777.40",
    "mcapval": "1,919.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500672,
    "symbol": "NOVARTIND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE234A01025",
    "curr_date": "Feb 04",
    "curr_time": "",
    "bse_nse_vol": "12.55 k",
    "exc_status": "Active",
    "traded_date": "Feb 04, 2026",
    "traded_date_str": "2026 02 04",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/novartis-india-333626-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "333626",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/novartis-india-333626"
  },
  "announcements": [
    {
      "caption": "Rumour verification - Regulation 30(11)",
      "datetime": "29-Jan-2026",
      "details": "Clarification regarding incorrect financial figures of Novartis India Limited for Q3 2025-26 reported in Free Press Journal article dated January 28 2026. The article has now been taken down.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "29-Jan-2026",
      "details": "Intimation of newspaper advertisement by Novartis India Limited (the Company) regarding the publication of Unaudited Financial Results of the Company for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Integrated Filing (Financial) For The Quarter Ended December 31 2025.",
      "datetime": "28-Jan-2026",
      "details": "Integrated Filing (Financial) for the Quarter ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Novartis India Ltd has declared <strong>500%</strong> dividend, ex-date: 23 Jul 25",
          "dt": "2025-07-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Rumour verification - Regulation 30(11)

29-Jan-2026 | Source : BSE

Clarification regarding incorrect financial figures of Novartis India Limited for Q3 2025-26 reported in Free Press Journal article dated January 28 2026. The article has now been taken down.

Announcement under Regulation 30 (LODR)-Newspaper Publication

29-Jan-2026 | Source : BSE

Intimation of newspaper advertisement by Novartis India Limited (the Company) regarding the publication of Unaudited Financial Results of the Company for the quarter ended December 31 2025.

Integrated Filing (Financial) For The Quarter Ended December 31 2025.

28-Jan-2026 | Source : BSE

Integrated Filing (Financial) for the Quarter ended December 31 2025.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Novartis India Ltd has declared 500% dividend, ex-date: 23 Jul 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available